Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrofurantoin Prophylaxis for UTI After Urogynecologic Surgery
NCT01450800Phase 4
Key facts
- Status
- Completed
- Start
- Aug 2011
- Primary completion
- Mar 2013
- Countries
- 1
- Sponsor
- Duke University
- Modality
- Metabolically Activated Prodrugs
- Drugs
- nitrofurantoin
- Conditions
- urinary tract infection (UTI)
01
Overview
Phase 4, randomised, triple-blind trial of nitrofurantoin in urinary tract infection (UTI), sponsored by Duke University. Primary endpoint: Urinary Tract Infection at 3 weeks. Started Aug 2011; status: completed.
02
Design
- Study design
- RandomizedTriple-blind
03
Who it enrols
Patients undergoing urogynecologic surgery requiring post-operative catheterization, excluding those with nitrofurantoin allergy, pregnancy, or specific complex surgeries.
04
Endpoints
Primary
Urinary Tract Infection
Secondary
Other Risk Factors for UTI
Beyond the preview
Go deeper on NCT01450800.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01450800.